Maky Zanganeh, DDS, MBA
Founder and CEO of Maky Zanganeh and Associates, Inc., an investment, consulting and management group.
Maky Zanganeh has more than 16 years of strategic planning, management, corporate, clinical, business and marketing experience in the pharmaceutical, medical device and technology industries.
Prior to founding Maky Zanganeh & Associates, Maky was the COO at Pharmacyclics, Inc. where she oversaw all clinical, research, commercial and business-related matters. Under her leadership, the company was able to achieve four FDA labels, with three Breakthrough Therapy Designations, in 14 months; a feat which has never been accomplished by any company before. Maky also drove the multi-million dollar collaboration and license deal for ibrutinib with Janssen Biotech Inc. in 2011 and the subsequent sale of the company for $21 billion dollars in 2015 to AbbVie, Inc.; the second largest biopharmaceutical sale ever in the industry.
- The deal with Janssen Biotech received the award of the “Best Biotech Transaction” in 2011.
- Under her leadership in 2015, Pharmacyclics was awarded the prestigious Prix Galien for Best Pharmaceutical Agent. This award is the biomedical industry’s highest accolade, the Prix Galien Award recognizes outstanding achievement in the development of new therapies.
Previously, Maky held senior and executive positions including International Product Manager for IRCAD-EITS, General Director Pos De Competitive for Therapeutic Innovation and President Director General (CEO) of Europe, Middle East and Africa and World-wide Vice President of Training and Education for Computer Motion (which was acquired in 2003 by Intuitive Surgical).
Maky is currently on the Board of Directors of Human Longevity Inc., Renovorx, Radial Medical and Pulse Biosciences.
Maky earned her Doctor of Dental Surgery and her Master of Business Administration in International Business in France. She is a licensed investment advisor (Series 65) and has her dentistry license. She is fluent in French, German, Farsi and English. Dr Zanganeh earned the Fierce Biotech “2013 Top Women in Biotech” award and the Ernst & Young Entrepreneur of the Year award in 2013.
Jacob Cynamon, MD
Mike Pishvaian, MD, PhD
Peter Muscarella, MD
Associate Program Director, General Surgery Residency Training Program Montefiore Medical Center, Bronx, NY
Karyn A. Goodman, MD, MS
Associate Director of Clinical Research, The Tisch Cancer Institute at Mount Sinai
Daniel D. Von Hoff, MD, FACP
Chief Scientific Officer for US Oncology and for HonorHealth’s Clinical Research Institute
Clinical Professor of Medicine, University of Arizona, Tucson, AZ